@Article{Paszkowski2007,
journal="Menopause Review/Przegląd Menopauzalny",
issn="1643-8876",
volume="6",
number="2",
year="2007",
title="Hormonal replacement therapy and obesity",
abstract="Obesity constitutes one of the most common disorders in the perimenopausal period \– it concerns approximately 65% of women in this period of life. Hormone replacement therapy (HRT) does not induce the obesity. The excessive BMI is not an absolute contraindication for HRT; however, hormone therapy should be applied with extreme caution in obese women. The available literature indicates that in peri- and postmenopausal women with indications for the HRT, for safety reasons, the choice of the route of administration and the application of minimally effective dose are crucial.",
author="Paszkowski, Tomasz
and Kłodnicka, Monika",
pages="106--109",
url="https://www.termedia.pl/Hormonal-replacement-therapy-and-obesity,4,8105,1,1.html"
}